Identification of serologic biomarkers for predicting microvascular invasion in hepatocellular carcinoma

Microvascular invasion (MVI) of hepatocellular carcinoma (HCC) is a major risk factor for early recurrence and poor survival after curative surgical therapies. However, MVI can only be diagnosed by pathological examination following resection. The aim of this study is to identify serologic biomarker...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Oncotarget
Autores principales: Yu, Yuan-Quan, Wang, Liang, Jin, Yun, Zhou, Jia-Le, Geng, Yan-Hua, Jin, Xing, Zhang, Xiao-Xiao, Yang, Jun-Jie, Qian, Cheng-Ming, Zhou, Dong-Er, Liu, Da-Ren, Peng, Shu-You, Luo, Yan, Zheng, Lei, Li, Jiang-Tao
Formato: Artigo
Lenguaje:Inglês
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4941320/
https://ncbi.nlm.nih.gov/pubmed/26918350
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.7649
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares